A Huge Amount of Data From Cancer Trials Remains Hidden, Researchers Warn - ScienceAlert

Data from more than half of cancer trials underpinning drug approvals remains inaccessible, according to a shocking new study that audited over 300 clinical trials backing anti-cancer medicines approved by the US drug regulator over the last 10 years

Data from more than half of cancer trials underpinning drug approvals remains inaccessible, according to a shocking new study that audited over 300 clinical trials backing anti-cancer medicines appro… [+4954 chars]

full article...